Kenneth T. Mills Regenxbio Inc. (RGNX) insider trading activity

Kenneth T. Mills is of REGENXBIO Inc.. Currently has a direct ownership of 482,871 shares of RGNX, which is worth approximately $4.42 Million. The most recent transaction as insider was on May 30, 2025, when has been sold 7,768 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 483K

8.67% 3M change

18.34% 12M change

Total Value Held $4.42 Million

Kenneth T. Mills Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 30 2025	BUY Grant, award, or other acquisition	-	7,768 Added 1.58%	482,871 Common Stock
May 12 2025	SELL Open market or private sale	$162,961 $7.91 p/Share	20,602 Reduced 4.16%	475,103 Common Stock
May 12 2025	BUY Exercise of conversion of derivative security	$77,463 $3.76 p/Share	20,602 Added 3.99%	495,705 Common Stock
Mar 27 2025	BUY Exercise of conversion of derivative security	$115,627 $3.76 p/Share	30,752 Added 6.08%	475,103 Common Stock
Aug 08 2024	BUY Exercise of conversion of derivative security	$30,868 $0.85 p/Share	36,316 Added 7.56%	444,351 Common Stock
Jul 25 2024	SELL Open market or private sale	$214,551 $13.96 p/Share	15,369 Reduced 3.63%	408,035 Common Stock
Jul 25 2024	BUY Exercise of conversion of derivative security	$57,787 $3.76 p/Share	15,369 Added 3.5%	423,404 Common Stock
Jul 24 2024	SELL Open market or private sale	$168,405 $13.78 p/Share	12,221 Reduced 2.91%	408,035 Common Stock
Jul 24 2024	BUY Exercise of conversion of derivative security	$45,950 $3.76 p/Share	12,221 Added 2.83%	420,256 Common Stock
Jul 17 2024	SELL Open market or private sale	$30,431 $13.77 p/Share	2,210 Reduced 0.54%	408,035 Common Stock
Jul 17 2024	BUY Exercise of conversion of derivative security	$8,309 $3.76 p/Share	2,210 Added 0.54%	410,245 Common Stock
Jul 16 2024	SELL Open market or private sale	$2,752 $13.76 p/Share	200 Reduced 0.05%	408,035 Common Stock
Jul 16 2024	BUY Exercise of conversion of derivative security	$752 $3.76 p/Share	200 Added 0.05%	408,235 Common Stock
May 14 2024	SELL Open market or private sale	$237,150 $15.81 p/Share	15,000 Reduced 3.55%	408,035 Common Stock
May 14 2024	BUY Exercise of conversion of derivative security	$56,400 $3.76 p/Share	15,000 Added 3.42%	423,035 Common Stock
Apr 15 2024	SELL Open market or private sale	$272,850 $18.19 p/Share	15,000 Reduced 3.55%	408,035 Common Stock
Apr 15 2024	BUY Exercise of conversion of derivative security	$56,400 $3.76 p/Share	15,000 Added 3.42%	423,035 Common Stock
Mar 14 2024	SELL Open market or private sale	$327,900 $21.86 p/Share	15,000 Reduced 3.55%	408,035 Common Stock
Mar 14 2024	BUY Exercise of conversion of derivative security	$56,400 $3.76 p/Share	15,000 Added 3.42%	423,035 Common Stock
Feb 14 2024	SELL Open market or private sale	$250,050 $16.67 p/Share	15,000 Reduced 3.55%	408,035 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	$56,400 $3.76 p/Share	15,000 Added 3.42%	423,035 Common Stock
Jan 16 2024	SELL Open market or private sale	$683,100 $15.18 p/Share	45,000 Reduced 9.93%	408,035 Common Stock
Jan 16 2024	BUY Exercise of conversion of derivative security	$169,200 $3.76 p/Share	45,000 Added 9.04%	453,035 Common Stock
Jan 02 2024	SELL Payment of exercise price or tax liability	$203,858 $17.95 p/Share	11,357 Reduced 3.2%	343,932 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	64,103 Added 13.58%	408,035 Common Stock

KTM

Kenneth T. Mills

Rockville, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGNX shares.

Notify only if

Value

Insider Trading

Get notified when an Regenxbio Inc. insider buys or sells RGNX shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGENXBIO Inc.

Track Activities on RGNX

Account